ONTOLOGY,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
BP,GO:0050905,neuromuscular process,6/17,176/18805,0.03409090909090909,37.710561497326196,14.718443868828638,7.011416032952242e-9,3.8127535746553685e-6,2.2253614594012475e-6,CSMD1/CNTNAP2/PRKN/DMD/PCDH15/CTNNA2,6
BP,GO:0001964,startle response,4/17,28/18805,0.14285714285714285,158.0252100840336,25.01178010432168,9.231848849044476e-9,3.8127535746553685e-6,2.2253614594012475e-6,CSMD1/CNTNAP2/PRKN/CTNNA2,4
BP,GO:0030534,adult behavior,4/17,152/18805,0.02631578947368421,29.10990712074303,10.466853984609816,8.997057972024654e-6,0.0022754528473818876,0.0013280966026518474,CNTNAP2/PRKN/DAB1/NRXN3,4
BP,GO:0007612,learning,4/17,160/18805,0.025,27.654411764705884,10.18491024723284,1.1019142118072094e-5,0.0022754528473818876,0.0013280966026518474,CSMD1/CNTNAP2/PRKN/NRXN3,4
BP,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,3/17,78/18805,0.038461538461538464,42.54524886877829,11.05971325484111,4.4767071467969096e-5,0.007395520206508494,0.004316488154174705,PTPRD/DAB1/ERBB4,3
BP,GO:0060134,prepulse inhibition,2/17,13/18805,0.15384615384615385,170.18099547511315,18.354647846477487,5.964841534890729e-5,0.008211598513032903,0.00479280249645606,CNTNAP2/CTNNA2,2
BP,GO:1904892,regulation of receptor signaling pathway via STAT,3/17,97/18805,0.030927835051546393,34.211643420254696,9.864426907005178,8.584500499575414e-5,0.008572341091320702,0.005003354428220827,PTPRD/DAB1/ERBB4,3
BP,GO:0007611,learning or memory,4/17,282/18805,0.014184397163120567,15.690446391322485,7.476755686055839,1.010049603259557e-4,0.008572341091320702,0.005003354428220827,CSMD1/CNTNAP2/PRKN/NRXN3,4
BP,GO:0021535,cell migration in hindbrain,2/17,17/18805,0.11764705882352941,130.13840830449828,16.02318770621006,1.0378136914431844e-4,0.008572341091320702,0.005003354428220827,DAB1/CTNNA2,2
BP,GO:0033137,negative regulation of peptidyl-serine phosphorylation,2/17,17/18805,0.11764705882352941,130.13840830449828,16.02318770621006,1.0378136914431844e-4,0.008572341091320702,0.005003354428220827,DMD/PDE4D,2
BP,GO:1901890,positive regulation of cell junction assembly,3/17,112/18805,0.026785714285714284,29.629726890756302,9.141048636582914,1.3159559789891105e-4,0.009815685176368256,0.005729047802697416,PTPRD/CNTNAP2/LINGO2,3
BP,GO:0071625,vocalization behavior,2/17,20/18805,0.1,110.61764705882354,14.753639928606837,1.4475757142575762e-4,0.009815685176368256,0.005729047802697416,CNTNAP2/NRXN3,2
BP,GO:0050807,regulation of synapse organization,4/17,315/18805,0.012698412698412698,14.046685340802988,7.024191055741055,1.5473410848620595e-4,0.009815685176368256,0.005729047802697416,PTPRD/DAB1/LINGO2/CTNNA2,4
BP,GO:0050803,regulation of synapse structure or activity,4/17,321/18805,0.012461059190031152,13.784130474619754,6.949203614405726,1.6636754536217382e-4,0.009815685176368256,0.005729047802697416,PTPRD/DAB1/LINGO2/CTNNA2,4
BP,GO:0050890,cognition,4/17,329/18805,0.0121580547112462,13.448954049704989,6.8522964306595755,1.828503448240691e-4,0.00993517518263381,0.005798789643999345,CSMD1/CNTNAP2/PRKN/NRXN3,4
BP,GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,2/17,23/18805,0.08695652173913043,96.18925831202046,13.740111247583965,1.924489139493232e-4,0.00993517518263381,0.005798789643999345,PTPRD/DAB1,2
BP,GO:0007259,cell surface receptor signaling pathway via JAK-STAT,3/17,131/18805,0.022900763358778626,25.33228558599012,8.406383174939219,2.0917030854837154e-4,0.010163216168291463,0.005931888626325336,PTPRD/DAB1/ERBB4,3
BP,GO:0097696,cell surface receptor signaling pathway via STAT,3/17,159/18805,0.018867924528301886,20.871254162042174,7.569031394951098,3.6970238950439e-4,0.016965231873923674,0.009901970432339804,PTPRD/DAB1/ERBB4,3
BP,GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/17,33/18805,0.06060606060606061,67.04099821746881,11.421539141238654,3.995030733722804e-4,0.017367870452921243,0.010136975490554263,DMD/PDE4D,2
BP,GO:1904893,negative regulation of receptor signaling pathway via STAT,2/17,35/18805,0.05714285714285714,63.21008403361344,11.080822039000925,4.49719267628442e-4,0.01857340575305465,0.010840601293359288,PTPRD/DAB1,2
BP,GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/17,38/18805,0.05263157894736842,58.21981424148606,10.620626132831273,5.305024469231969e-4,0.02086642957897908,0.012178953418086428,DMD/PDE4D,2
BP,GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,2/17,40/18805,0.05,55.30882352941177,10.342735357870833,5.879833912798214e-4,0.02123111592295909,0.01239180717817671,DMD/PDE4D,2
BP,GO:0010975,regulation of neuron projection development,4/17,448/18805,0.008928571428571428,9.8765756302521,5.719959014539627,5.91181193980701e-4,0.02123111592295909,0.01239180717817671,PTPRD/DMD/DAB1/CTNNA2,4
BP,GO:0001764,neuron migration,3/17,191/18805,0.015706806282722512,17.37449953803511,6.8418597959475855,6.315066610538166e-4,0.021734354251268854,0.012685528542221405,DAB1/CTNNA2/ERBB4,3
BP,GO:0070296,sarcoplasmic reticulum calcium ion transport,2/17,45/18805,0.044444444444444446,49.16339869281046,9.730076880034243,7.443063688159751e-4,0.024591882425679817,0.014353360712324913,DMD/PDE4D,2
BP,GO:0001933,negative regulation of protein phosphorylation,3/17,210/18805,0.014285714285714285,15.80252100840336,6.488682862654504,8.316578107371534e-4,0.026421128910341873,0.015421023373182846,PRKN/DMD/PDE4D,3
BP,GO:2001222,regulation of neuron migration,2/17,52/18805,0.038461538461538464,42.54524886877829,9.02395593774931,9.932186096457613e-4,0.030338320683948313,0.017707341497704,CTNNA2/ERBB4,2
BP,GO:0042326,negative regulation of phosphorylation,3/17,226/18805,0.01327433628318584,14.683758459135866,6.225263775233957,0.0010284176503033327,0.030338320683948313,0.017707341497704,PRKN/DMD/PDE4D,3
BP,GO:0035176,social behavior,2/17,55/18805,0.03636363636363636,40.22459893048128,8.762913536715393,0.0011105436603416699,0.03163134701524894,0.018462032538529394,CNTNAP2/NRXN3,2
BP,GO:0051703,biological process involved in intraspecies interaction between organisms,2/17,57/18805,0.03508771929824561,38.81320949432404,8.600284189669944,0.0011922866338851083,0.03282762531963665,0.01916025537962736,CNTNAP2/NRXN3,2
BP,GO:0016358,dendrite development,3/17,242/18805,0.012396694214876033,13.712931453573166,5.987404676044063,0.0012525318676662363,0.03337391363523584,0.019479103408867104,PTPRD/DAB1/CTNNA2,3
BP,GO:0033135,regulation of peptidyl-serine phosphorylation,2/17,66/18805,0.030303030303030304,33.520499108734406,7.960956863076218,0.0015947739073811887,0.03846926577762939,0.02245306961406176,DMD/PDE4D,2
BP,GO:0051965,positive regulation of synapse assembly,2/17,66/18805,0.030303030303030304,33.520499108734406,7.960956863076218,0.0015947739073811887,0.03846926577762939,0.02245306961406176,PTPRD/LINGO2,2
BP,GO:1901888,regulation of cell junction assembly,3/17,270/18805,0.011111111111111112,12.290849673202615,5.6211026767257195,0.0017147311613604384,0.03846926577762939,0.02245306961406176,PTPRD/CNTNAP2/LINGO2,3
BP,GO:0010563,negative regulation of phosphorus metabolic process,3/17,271/18805,0.01107011070110701,12.245495984371606,5.609032896367978,0.0017329565425872866,0.03846926577762939,0.02245306961406176,PRKN/DMD/PDE4D,3
BP,GO:0045936,negative regulation of phosphate metabolic process,3/17,271/18805,0.01107011070110701,12.245495984371606,5.609032896367978,0.0017329565425872866,0.03846926577762939,0.02245306961406176,PRKN/DMD/PDE4D,3
BP,GO:0061180,mammary gland epithelium development,2/17,69/18805,0.028985507246376812,32.06308610400682,7.775709252760856,0.0017414377708737721,0.03846926577762939,0.02245306961406176,CSMD1/ERBB4,2
BP,GO:0007416,synapse assembly,3/17,273/18805,0.01098901098901099,12.15578539107951,5.58508304300449,0.0017697725176149114,0.03846926577762939,0.02245306961406176,PTPRD/LINGO2/ERBB4,3
BP,GO:0021537,telencephalon development,3/17,280/18805,0.010714285714285714,11.851890756302522,5.5031915132883205,0.0019024951189607103,0.039286524206538664,0.022930072749579093,CNTNAP2/DAB1/ERBB4,3
BP,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,3/17,280/18805,0.010714285714285714,11.851890756302522,5.5031915132883205,0.0019024951189607103,0.039286524206538664,0.022930072749579093,PTPRD/PCDH15/DAB1,3
BP,GO:0055117,regulation of cardiac muscle contraction,2/17,79/18805,0.02531645569620253,28.00446760982874,7.234957127500763,0.0022749184066746266,0.04583128302227418,0.026750003344209988,DMD/PDE4D,2
BP,GO:0042246,tissue regeneration,2/17,82/18805,0.024390243902439025,26.979913916786227,7.091959085952228,0.002448225289281137,0.047121203198894325,0.027502881438885695,EYS/ERBB4,2
BP,GO:1904062,regulation of monoatomic cation transmembrane transport,3/17,311/18805,0.00964630225080386,10.670512578021562,5.1727747601761225,0.0025648841608781323,0.047121203198894325,0.027502881438885695,DMD/KCNIP4/PDE4D,3
BP,GO:0008344,adult locomotory behavior,2/17,84/18805,0.023809523809523808,26.337535014005603,7.0008180318885085,0.002567135767494243,0.047121203198894325,0.027502881438885695,PRKN/DAB1,2
BP,GO:0051279,regulation of release of sequestered calcium ion into cytosol,2/17,84/18805,0.023809523809523808,26.337535014005603,7.0008180318885085,0.002567135767494243,0.047121203198894325,0.027502881438885695,DMD/PDE4D,2
BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,2/17,86/18805,0.023255813953488372,25.7250341997264,6.912801886640494,0.00268873383820302,0.04828030761642814,0.02817940727453051,PRKN/WWOX,2
BP,GO:0031400,negative regulation of protein modification process,3/17,321/18805,0.009345794392523364,10.338097855964815,5.076007594038201,0.002805459128916214,0.049304451925208354,0.028777161949465314,PRKN/DMD/PDE4D,3
BP,GO:0045666,positive regulation of neuron differentiation,2/17,96/18805,0.020833333333333332,23.0453431372549,6.513831173393837,0.0033367260084480664,0.057419493395377136,0.033513607716430145,DMD/DAB1,2
BP,GO:0034765,regulation of monoatomic ion transmembrane transport,3/17,345/18805,0.008695652173913044,9.618925831202047,4.860222468979766,0.0034387469802919903,0.057967449096350696,0.03383342893606298,DMD/KCNIP4/PDE4D,3
BP,GO:0006942,regulation of striated muscle contraction,2/17,101/18805,0.019801980198019802,21.90448456610367,6.336394523787915,0.003685487665011433,0.06088425622598887,0.03553586001211024,DMD/PDE4D,2
BP,GO:0002027,regulation of heart rate,2/17,106/18805,0.018867924528301886,20.871254162042174,6.1713236925498896,0.004050576099542464,0.06553263131317359,0.038248942451170526,DMD/PDE4D,2
BP,GO:0008637,apoptotic mitochondrial changes,2/17,107/18805,0.018691588785046728,20.67619571192963,6.13966607038431,0.004125540954340226,0.06553263131317359,0.038248942451170526,PRKN/ERBB4,2
BP,GO:0032970,regulation of actin filament-based process,3/17,392/18805,0.007653061224489796,8.465636254501801,4.493211784526909,0.0049185681320504954,0.07665542032214546,0.04474089780494791,PRKN/CTNNA2/PDE4D,3
BP,GO:0010959,regulation of metal ion transport,3/17,403/18805,0.007444168734491315,8.234564297182894,4.416128448238691,0.005312689799029946,0.08126447729627288,0.047431031734029544,DMD/KCNIP4/PDE4D,3
BP,GO:0021761,limbic system development,2/17,125/18805,0.016,17.698823529411765,5.634582627599858,0.005584411225067502,0.0838677031255592,0.048950437149874,CNTNAP2/DAB1,2
BP,GO:0030900,forebrain development,3/17,413/18805,0.007263922518159807,8.035180173764422,4.348556100492261,0.005687202568780012,0.08388623788950518,0.04896125519739185,CNTNAP2/DAB1/ERBB4,3
BP,GO:0021987,cerebral cortex development,2/17,130/18805,0.015384615384615385,17.018099547511312,5.5126658107268875,0.006025978660232704,0.08689751741048499,0.05071882626991478,CNTNAP2/DAB1,2
BP,GO:0051209,release of sequestered calcium ion into cytosol,2/17,131/18805,0.015267175572519083,16.88819039066008,5.489094557445826,0.006116161735452615,0.08689751741048499,0.05071882626991478,DMD/PDE4D,2
BP,GO:0051283,negative regulation of sequestering of calcium ion,2/17,132/18805,0.015151515151515152,16.760249554367203,5.465782089555064,0.006206965529320356,0.08689751741048499,0.05071882626991478,DMD/PDE4D,2
BP,GO:0051282,regulation of sequestering of calcium ion,2/17,134/18805,0.014925373134328358,16.51009657594381,5.419914280265714,0.006390431036951475,0.08797493394203199,0.05134767394603116,DMD/PDE4D,2
BP,GO:0030879,mammary gland development,2/17,137/18805,0.014598540145985401,16.148561614426793,5.352936497740483,0.00667025824481865,0.08918772618052094,0.052055535351954375,CSMD1/ERBB4,2
BP,GO:0051208,sequestering of calcium ion,2/17,138/18805,0.014492753623188406,16.03154305200341,5.3310793980930935,0.006764764147418386,0.08918772618052094,0.052055535351954375,DMD/PDE4D,2
BP,GO:0018105,peptidyl-serine phosphorylation,2/17,142/18805,0.014084507042253521,15.579950289975145,5.245885336278474,0.007148910544545351,0.08918772618052094,0.052055535351954375,DMD/PDE4D,2
BP,GO:0048813,dendrite morphogenesis,2/17,144/18805,0.013888888888888888,15.363562091503267,5.204574768098185,0.0073446427329721935,0.08918772618052094,0.052055535351954375,PTPRD/CTNNA2,2
BP,GO:0051960,regulation of nervous system development,3/17,454/18805,0.006607929515418502,7.309536149261468,4.093594287451563,0.007388245184212997,0.08918772618052094,0.052055535351954375,PTPRD/DAB1/LINGO2,3
BP,GO:0007409,axonogenesis,3/17,459/18805,0.006535947712418301,7.229911572472126,4.064684456038594,0.007614272393635759,0.08918772618052094,0.052055535351954375,DAB1/NRXN3/CTNNA2,3
BP,GO:0060048,cardiac muscle contraction,2/17,147/18805,0.013605442176870748,15.0500200080032,5.144135170952932,0.007642791224303442,0.08918772618052094,0.052055535351954375,DMD/PDE4D,2
BP,GO:0043269,regulation of monoatomic ion transport,3/17,472/18805,0.006355932203389831,7.030782652043869,3.991509922055216,0.008221222369010728,0.08918772618052094,0.052055535351954375,DMD/KCNIP4/PDE4D,3
BP,GO:0018209,peptidyl-serine modification,2/17,154/18805,0.012987012987012988,14.365928189457602,5.0097693229403655,0.008359559616181724,0.08918772618052094,0.052055535351954375,DMD/PDE4D,2
BP,GO:0034762,regulation of transmembrane transport,3/17,478/18805,0.006276150627615063,6.942530150135368,3.9586668874193256,0.008510814366993255,0.08918772618052094,0.052055535351954375,DMD/KCNIP4/PDE4D,3
BP,GO:0071287,cellular response to manganese ion,1/17,10/18805,0.1,110.61764705882354,10.429623159173875,0.009005607954727268,0.08918772618052094,0.052055535351954375,PRKN,1
BP,GO:0098598,learned vocalization behavior or vocal learning,1/17,10/18805,0.1,110.61764705882354,10.429623159173875,0.009005607954727268,0.08918772618052094,0.052055535351954375,CNTNAP2,1
BP,GO:1903596,regulation of gap junction assembly,1/17,10/18805,0.1,110.61764705882354,10.429623159173875,0.009005607954727268,0.08918772618052094,0.052055535351954375,CNTNAP2,1
BP,GO:2001241,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/17,10/18805,0.1,110.61764705882354,10.429623159173875,0.009005607954727268,0.08918772618052094,0.052055535351954375,WWOX,1
BP,GO:0030902,hindbrain development,2/17,161/18805,0.012422360248447204,13.741322616002922,4.88390502076177,0.009105564566032426,0.08918772618052094,0.052055535351954375,DAB1/CTNNA2,2
BP,GO:0051494,negative regulation of cytoskeleton organization,2/17,162/18805,0.012345679012345678,13.656499636891793,4.866564958569961,0.009214502761795803,0.08918772618052094,0.052055535351954375,PRKN/CTNNA2,2
BP,GO:0010976,positive regulation of neuron projection development,2/17,165/18805,0.012121212121212121,13.408199643493761,4.815452427835185,0.009544843899068784,0.08918772618052094,0.052055535351954375,PTPRD/DMD,2
BP,GO:0072331,signal transduction by p53 class mediator,2/17,165/18805,0.012121212121212121,13.408199643493761,4.815452427835185,0.009544843899068784,0.08918772618052094,0.052055535351954375,PRKN/WWOX,2
BP,GO:1902904,negative regulation of supramolecular fiber organization,2/17,167/18805,0.011976047904191617,13.247622402254317,4.782111264409443,0.00976799990844609,0.08918772618052094,0.052055535351954375,PRKN/CTNNA2,2
BP,GO:0021889,olfactory bulb interneuron differentiation,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,ERBB4,1
BP,GO:0032754,positive regulation of interleukin-5 production,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,PDE4D,1
BP,GO:0035519,protein K29-linked ubiquitination,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,PRKN,1
BP,GO:0038130,ERBB4 signaling pathway,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,ERBB4,1
BP,GO:0097090,presynaptic membrane organization,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,PTPRD,1
BP,GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,PDE4D,1
BP,GO:1905091,positive regulation of type 2 mitophagy,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,PRKN,1
BP,GO:2000169,regulation of peptidyl-cysteine S-nitrosylation,1/17,11/18805,0.09090909090909091,100.56149732620321,9.93544805150441,0.009901958296029245,0.08918772618052094,0.052055535351954375,DMD,1
BP,GO:0051963,regulation of synapse assembly,2/17,169/18805,0.011834319526627219,13.090845805777931,4.749337035448236,0.009993489280782983,0.08918772618052094,0.052055535351954375,PTPRD/LINGO2,2
BP,GO:0048639,positive regulation of developmental growth,2/17,171/18805,0.011695906432748537,12.937736498108015,4.717113263327641,0.01022130389038568,0.08918772618052094,0.052055535351954375,PRKN/ERBB4,2
BP,GO:0006937,regulation of muscle contraction,2/17,175/18805,0.011428571428571429,12.642016806722689,4.654254475052922,0.010683876412429426,0.08918772618052094,0.052055535351954375,DMD/PDE4D,2
BP,GO:1903169,regulation of calcium ion transmembrane transport,2/17,175/18805,0.011428571428571429,12.642016806722689,4.654254475052922,0.010683876412429426,0.08918772618052094,0.052055535351954375,DMD/PDE4D,2
BP,GO:0031223,auditory behavior,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,CNTNAP2,1
BP,GO:0038026,reelin-mediated signaling pathway,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,DAB1,1
BP,GO:0044314,protein K27-linked ubiquitination,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,PRKN,1
BP,GO:0045161,neuronal ion channel clustering,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,CNTNAP2,1
BP,GO:0051583,dopamine uptake involved in synaptic transmission,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,PRKN,1
BP,GO:0051934,catecholamine uptake involved in synaptic transmission,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,PRKN,1
BP,GO:0071872,cellular response to epinephrine stimulus,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,PDE4D,1
BP,GO:2000651,positive regulation of sodium ion transmembrane transporter activity,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,DMD,1
BP,GO:2001223,negative regulation of neuron migration,1/17,12/18805,0.08333333333333333,92.1813725490196,9.504034358208402,0.010797545542435949,0.08918772618052094,0.052055535351954375,ERBB4,1
BP,GO:0030178,negative regulation of Wnt signaling pathway,2/17,181/18805,0.011049723756906077,12.22294442638934,4.5637193005210985,0.011394972410047452,0.09026072775981034,0.05268180618579475,PRKN/WWOX,2
BP,GO:0010992,ubiquitin recycling,1/17,13/18805,0.07692307692307693,85.09049773755657,9.123078327287105,0.011692370303026278,0.09026072775981034,0.05268180618579475,PRKN,1
BP,GO:0021794,thalamus development,1/17,13/18805,0.07692307692307693,85.09049773755657,9.123078327287105,0.011692370303026278,0.09026072775981034,0.05268180618579475,CNTNAP2,1
BP,GO:0044828,negative regulation by host of viral genome replication,1/17,13/18805,0.07692307692307693,85.09049773755657,9.123078327287105,0.011692370303026278,0.09026072775981034,0.05268180618579475,PRKN,1
BP,GO:0097475,motor neuron migration,1/17,13/18805,0.07692307692307693,85.09049773755657,9.123078327287105,0.011692370303026278,0.09026072775981034,0.05268180618579475,DAB1,1
BP,GO:0098814,spontaneous synaptic transmission,1/17,13/18805,0.07692307692307693,85.09049773755657,9.123078327287105,0.011692370303026278,0.09026072775981034,0.05268180618579475,PRKN,1
BP,GO:1905089,regulation of type 2 mitophagy,1/17,13/18805,0.07692307692307693,85.09049773755657,9.123078327287105,0.011692370303026278,0.09026072775981034,0.05268180618579475,PRKN,1
BP,GO:0007638,mechanosensory behavior,1/17,14/18805,0.07142857142857142,79.0126050420168,8.783410050432641,0.012586433186426382,0.09126443397923727,0.05326763191345823,CNTNAP2,1
BP,GO:0009214,cyclic nucleotide catabolic process,1/17,14/18805,0.07142857142857142,79.0126050420168,8.783410050432641,0.012586433186426382,0.09126443397923727,0.05326763191345823,PDE4D,1
BP,GO:0051645,Golgi localization,1/17,14/18805,0.07142857142857142,79.0126050420168,8.783410050432641,0.012586433186426382,0.09126443397923727,0.05326763191345823,DAB1,1
BP,GO:1901077,regulation of relaxation of muscle,1/17,14/18805,0.07142857142857142,79.0126050420168,8.783410050432641,0.012586433186426382,0.09126443397923727,0.05326763191345823,PDE4D,1
BP,GO:1903265,positive regulation of tumor necrosis factor-mediated signaling pathway,1/17,14/18805,0.07142857142857142,79.0126050420168,8.783410050432641,0.012586433186426382,0.09126443397923727,0.05326763191345823,PRKN,1
BP,GO:1903377,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,1/17,14/18805,0.07142857142857142,79.0126050420168,8.783410050432641,0.012586433186426382,0.09126443397923727,0.05326763191345823,PRKN,1
BP,GO:0097553,calcium ion transmembrane import into cytosol,2/17,191/18805,0.010471204188481676,11.582999692023407,4.421961107586272,0.012625563758786942,0.09126443397923727,0.05326763191345823,DMD/PDE4D,2
BP,GO:0006941,striated muscle contraction,2/17,194/18805,0.010309278350515464,11.403881140084899,4.381478636952413,0.013005692095880443,0.09126443397923727,0.05326763191345823,DMD/PDE4D,2
BP,GO:0021543,pallium development,2/17,194/18805,0.010309278350515464,11.403881140084899,4.381478636952413,0.013005692095880443,0.09126443397923727,0.05326763191345823,CNTNAP2/DAB1,2
BP,GO:0045664,regulation of neuron differentiation,2/17,195/18805,0.010256410256410256,11.345399698340874,4.36818174691899,0.01313351547544977,0.09126443397923727,0.05326763191345823,DMD/DAB1,2
BP,GO:0010635,regulation of mitochondrial fusion,1/17,15/18805,0.06666666666666667,73.74509803921569,8.478036445480527,0.013479734800807441,0.09126443397923727,0.05326763191345823,PRKN,1
BP,GO:0017014,protein nitrosylation,1/17,15/18805,0.06666666666666667,73.74509803921569,8.478036445480527,0.013479734800807441,0.09126443397923727,0.05326763191345823,DMD,1
BP,GO:0018119,peptidyl-cysteine S-nitrosylation,1/17,15/18805,0.06666666666666667,73.74509803921569,8.478036445480527,0.013479734800807441,0.09126443397923727,0.05326763191345823,DMD,1
BP,GO:0071871,response to epinephrine,1/17,15/18805,0.06666666666666667,73.74509803921569,8.478036445480527,0.013479734800807441,0.09126443397923727,0.05326763191345823,PDE4D,1
BP,GO:0106072,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,1/17,15/18805,0.06666666666666667,73.74509803921569,8.478036445480527,0.013479734800807441,0.09126443397923727,0.05326763191345823,PDE4D,1
BP,GO:0031099,regeneration,2/17,203/18805,0.009852216748768473,10.898290350623009,4.265183241447093,0.014176011690406363,0.09195259834206572,0.053669287677668036,EYS/ERBB4,2
BP,GO:0007158,neuron cell-cell adhesion,1/17,16/18805,0.0625,69.13602941176471,8.201518823946232,0.014372275753887886,0.09195259834206572,0.053669287677668036,NRXN3,1
BP,GO:0010649,regulation of cell communication by electrical coupling,1/17,16/18805,0.0625,69.13602941176471,8.201518823946232,0.014372275753887886,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0021819,layer formation in cerebral cortex,1/17,16/18805,0.0625,69.13602941176471,8.201518823946232,0.014372275753887886,0.09195259834206572,0.053669287677668036,DAB1,1
BP,GO:0042415,norepinephrine metabolic process,1/17,16/18805,0.0625,69.13602941176471,8.201518823946232,0.014372275753887886,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0061734,type 2 mitophagy,1/17,16/18805,0.0625,69.13602941176471,8.201518823946232,0.014372275753887886,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0085020,protein K6-linked ubiquitination,1/17,16/18805,0.0625,69.13602941176471,8.201518823946232,0.014372275753887886,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0010042,response to manganese ion,1/17,17/18805,0.058823529411764705,65.06920415224914,7.949555037865691,0.01526405665293451,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0044793,negative regulation by host of viral process,1/17,17/18805,0.058823529411764705,65.06920415224914,7.949555037865691,0.01526405665293451,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0048532,anatomical structure arrangement,1/17,17/18805,0.058823529411764705,65.06920415224914,7.949555037865691,0.01526405665293451,0.09195259834206572,0.053669287677668036,DAB1,1
BP,GO:0048712,negative regulation of astrocyte differentiation,1/17,17/18805,0.058823529411764705,65.06920415224914,7.949555037865691,0.01526405665293451,0.09195259834206572,0.053669287677668036,DAB1,1
BP,GO:0060644,mammary gland epithelial cell differentiation,1/17,17/18805,0.058823529411764705,65.06920415224914,7.949555037865691,0.01526405665293451,0.09195259834206572,0.053669287677668036,ERBB4,1
BP,GO:0099151,regulation of postsynaptic density assembly,1/17,17/18805,0.058823529411764705,65.06920415224914,7.949555037865691,0.01526405665293451,0.09195259834206572,0.053669287677668036,PTPRD,1
BP,GO:1903541,regulation of exosomal secretion,1/17,17/18805,0.058823529411764705,65.06920415224914,7.949555037865691,0.01526405665293451,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0051651,maintenance of location in cell,2/17,212/18805,0.009433962264150943,10.435627081021087,4.155978289631675,0.015390678234674325,0.09195259834206572,0.053669287677668036,DMD/PDE4D,2
BP,GO:0008016,regulation of heart contraction,2/17,214/18805,0.009345794392523364,10.338097855964815,4.132598732105944,0.015666555266192938,0.09195259834206572,0.053669287677668036,DMD/PDE4D,2
BP,GO:0007626,locomotory behavior,2/17,215/18805,0.009302325581395349,10.29001367989056,4.121024483923163,0.015805299502670258,0.09195259834206572,0.053669287677668036,PRKN/DAB1,2
BP,GO:0016264,gap junction assembly,1/17,18/18805,0.05555555555555555,61.45424836601307,7.718691207368627,0.016155078104760134,0.09195259834206572,0.053669287677668036,CNTNAP2,1
BP,GO:0055119,relaxation of cardiac muscle,1/17,18/18805,0.05555555555555555,61.45424836601307,7.718691207368627,0.016155078104760134,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0090494,dopamine uptake,1/17,18/18805,0.05555555555555555,61.45424836601307,7.718691207368627,0.016155078104760134,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1902916,positive regulation of protein polyubiquitination,1/17,18/18805,0.05555555555555555,61.45424836601307,7.718691207368627,0.016155078104760134,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0009612,response to mechanical stimulus,2/17,223/18805,0.008968609865470852,9.920865207069376,4.031089931473942,0.016934463891605116,0.09195259834206572,0.053669287677668036,CNTNAP2/DMD,2
BP,GO:0014819,regulation of skeletal muscle contraction,1/17,19/18805,0.05263157894736842,58.21981424148606,7.506118065393356,0.01704534071572561,0.09195259834206572,0.053669287677668036,DMD,1
BP,GO:0042053,regulation of dopamine metabolic process,1/17,19/18805,0.05263157894736842,58.21981424148606,7.506118065393356,0.01704534071572561,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0042069,regulation of catecholamine metabolic process,1/17,19/18805,0.05263157894736842,58.21981424148606,7.506118065393356,0.01704534071572561,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,1/17,19/18805,0.05263157894736842,58.21981424148606,7.506118065393356,0.01704534071572561,0.09195259834206572,0.053669287677668036,DMD,1
BP,GO:0090493,catecholamine uptake,1/17,19/18805,0.05263157894736842,58.21981424148606,7.506118065393356,0.01704534071572561,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1902514,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,1/17,19/18805,0.05263157894736842,58.21981424148606,7.506118065393356,0.01704534071572561,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0051235,maintenance of location,2/17,224/18805,0.008928571428571428,9.8765756302521,4.020168269119106,0.01707799639367891,0.09195259834206572,0.053669287677668036,DMD/PDE4D,2
BP,GO:0050953,sensory perception of light stimulus,2/17,226/18805,0.008849557522123894,9.789172306090578,3.9985297997470233,0.017366642207308252,0.09195259834206572,0.053669287677668036,EYS/PCDH15,2
BP,GO:0032634,interleukin-5 production,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0032674,regulation of interleukin-5 production,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0051580,regulation of neurotransmitter uptake,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0060749,mammary gland alveolus development,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,ERBB4,1
BP,GO:0061003,positive regulation of dendritic spine morphogenesis,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,PTPRD,1
BP,GO:0061377,mammary gland lobule development,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,ERBB4,1
BP,GO:0090201,negative regulation of release of cytochrome c from mitochondria,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1990182,exosomal secretion,1/17,20/18805,0.05,55.30882352941177,7.309524048342507,0.01793484509174159,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0061577,calcium ion transmembrane transport via high voltage-gated calcium channel,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0090141,positive regulation of mitochondrial fission,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0097734,extracellular exosome biogenesis,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0099150,regulation of postsynaptic specialization assembly,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,PTPRD,1
BP,GO:0106070,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1905874,regulation of postsynaptic density organization,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,PTPRD,1
BP,GO:2000010,positive regulation of protein localization to cell surface,1/17,21/18805,0.047619047619047616,52.675070028011206,7.1269873444829015,0.018823591838265097,0.09195259834206572,0.053669287677668036,ERBB4,1
BP,GO:0021756,striatum development,1/17,22/18805,0.045454545454545456,50.280748663101605,6.9568952505941954,0.01971158156030206,0.09195259834206572,0.053669287677668036,CNTNAP2,1
BP,GO:1900242,regulation of synaptic vesicle endocytosis,1/17,22/18805,0.045454545454545456,50.280748663101605,6.9568952505941954,0.01971158156030206,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1902307,positive regulation of sodium ion transmembrane transport,1/17,22/18805,0.045454545454545456,50.280748663101605,6.9568952505941954,0.01971158156030206,0.09195259834206572,0.053669287677668036,DMD,1
BP,GO:1904889,regulation of excitatory synapse assembly,1/17,22/18805,0.045454545454545456,50.280748663101605,6.9568952505941954,0.01971158156030206,0.09195259834206572,0.053669287677668036,PTPRD,1
BP,GO:0022604,regulation of cell morphogenesis,2/17,247/18805,0.008097165991902834,8.956894498690165,3.786481134527828,0.020522852656846297,0.09195259834206572,0.053669287677668036,PTPRD/PRKN,2
BP,GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,DMD,1
BP,GO:0033238,regulation of amine metabolic process,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0038128,ERBB2 signaling pathway,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,ERBB4,1
BP,GO:0046058,cAMP metabolic process,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0050908,detection of light stimulus involved in visual perception,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,EYS,1
BP,GO:0050962,detection of light stimulus involved in sensory perception,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,EYS,1
BP,GO:0051354,negative regulation of oxidoreductase activity,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0060444,branching involved in mammary gland duct morphogenesis,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,CSMD1,1
BP,GO:0140112,extracellular vesicle biogenesis,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/17,23/18805,0.043478260869565216,48.09462915601023,6.797883030522343,0.020598814862409776,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0051924,regulation of calcium ion transport,2/17,253/18805,0.007905138339920948,8.744478028365496,3.7304940440076786,0.02146596309424793,0.09195259834206572,0.053669287677668036,DMD/PDE4D,2
BP,GO:0014059,regulation of dopamine secretion,1/17,24/18805,0.041666666666666664,46.0906862745098,6.648786935952746,0.0214852923486909,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,1/17,24/18805,0.041666666666666664,46.0906862745098,6.648786935952746,0.0214852923486909,0.09195259834206572,0.053669287677668036,ERBB4,1
BP,GO:0045822,negative regulation of heart contraction,1/17,24/18805,0.041666666666666664,46.0906862745098,6.648786935952746,0.0214852923486909,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:0051590,positive regulation of neurotransmitter transport,1/17,24/18805,0.041666666666666664,46.0906862745098,6.648786935952746,0.0214852923486909,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,1/17,24/18805,0.041666666666666664,46.0906862745098,6.648786935952746,0.0214852923486909,0.09195259834206572,0.053669287677668036,PDE4D,1
BP,GO:1900407,regulation of cellular response to oxidative stress,1/17,24/18805,0.041666666666666664,46.0906862745098,6.648786935952746,0.0214852923486909,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:1903861,positive regulation of dendrite extension,1/17,24/18805,0.041666666666666664,46.0906862745098,6.648786935952746,0.0214852923486909,0.09195259834206572,0.053669287677668036,PRKN,1
BP,GO:0060047,heart contraction,2/17,254/18805,0.007874015748031496,8.710050949513663,3.721343415748992,0.021624903959986338,0.09207304469561194,0.05373958770305884,DMD/PDE4D,2
BP,GO:0090257,regulation of muscle system process,2/17,256/18805,0.0078125,8.642003676470589,3.703192434482243,0.021944282373616602,0.09262383190431782,0.0540610615677043,DMD/PDE4D,2
BP,GO:0035994,response to muscle stretch,1/17,25/18805,0.04,44.247058823529414,6.508607668666463,0.022371014622801222,0.09262383190431782,0.0540610615677043,DMD,1
BP,GO:0036120,cellular response to platelet-derived growth factor stimulus,1/17,25/18805,0.04,44.247058823529414,6.508607668666463,0.022371014622801222,0.09262383190431782,0.0540610615677043,PTPRD,1
BP,GO:0046716,muscle cell cellular homeostasis,1/17,25/18805,0.04,44.247058823529414,6.508607668666463,0.022371014622801222,0.09262383190431782,0.0540610615677043,DMD,1
BP,GO:1901526,positive regulation of mitophagy,1/17,25/18805,0.04,44.247058823529414,6.508607668666463,0.022371014622801222,0.09262383190431782,0.0540610615677043,PRKN,1
BP,GO:0045927,positive regulation of growth,2/17,259/18805,0.007722007722007722,8.541903247785601,3.6763344779173917,0.022427077942934096,0.09262383190431782,0.0540610615677043,PRKN/ERBB4,2
BP,GO:0003015,heart process,2/17,263/18805,0.0076045627376425855,8.411988369492283,3.6411923467857163,0.023077725801678082,0.0940556691137824,0.05489677131911857,DMD/PDE4D,2
BP,GO:0090128,regulation of synapse maturation,1/17,26/18805,0.038461538461538464,42.54524886877829,6.376481647757852,0.02325598228794601,0.0940556691137824,0.05489677131911857,DAB1,1
BP,GO:1901385,regulation of voltage-gated calcium channel activity,1/17,26/18805,0.038461538461538464,42.54524886877829,6.376481647757852,0.02325598228794601,0.0940556691137824,0.05489677131911857,DMD,1
BP,GO:1903523,negative regulation of blood circulation,1/17,26/18805,0.038461538461538464,42.54524886877829,6.376481647757852,0.02325598228794601,0.0940556691137824,0.05489677131911857,PDE4D,1
BP,GO:0110053,regulation of actin filament organization,2/17,267/18805,0.00749063670411985,8.285966071821989,3.6067882195420724,0.023736229286977693,0.0940556691137824,0.05489677131911857,PRKN/CTNNA2,2
BP,GO:1903522,regulation of blood circulation,2/17,269/18805,0.007434944237918215,8.224360376120709,3.5898544269947283,0.02406840874126737,0.0940556691137824,0.05489677131911857,DMD/PDE4D,2
BP,GO:0010460,positive regulation of heart rate,1/17,27/18805,0.037037037037037035,40.96949891067538,6.251658184804371,0.024140195946878773,0.0940556691137824,0.05489677131911857,PDE4D,1
BP,GO:0036119,response to platelet-derived growth factor,1/17,27/18805,0.037037037037037035,40.96949891067538,6.251658184804371,0.024140195946878773,0.0940556691137824,0.05489677131911857,PTPRD,1
BP,GO:0042278,purine nucleoside metabolic process,1/17,27/18805,0.037037037037037035,40.96949891067538,6.251658184804371,0.024140195946878773,0.0940556691137824,0.05489677131911857,MACROD2,1
BP,GO:0043043,peptide biosynthetic process,1/17,27/18805,0.037037037037037035,40.96949891067538,6.251658184804371,0.024140195946878773,0.0940556691137824,0.05489677131911857,DMD,1
BP,GO:0044827,modulation by host of viral genome replication,1/17,27/18805,0.037037037037037035,40.96949891067538,6.251658184804371,0.024140195946878773,0.0940556691137824,0.05489677131911857,PRKN,1
BP,GO:1903859,regulation of dendrite extension,1/17,27/18805,0.037037037037037035,40.96949891067538,6.251658184804371,0.024140195946878773,0.0940556691137824,0.05489677131911857,PRKN,1
BP,GO:0001894,tissue homeostasis,2/17,272/18805,0.007352941176470588,8.133650519031143,3.564779934229079,0.024570317223641308,0.09438146129120856,0.055086924010925874,DMD/PCDH15,2
BP,GO:0060249,anatomical structure homeostasis,2/17,272/18805,0.007352941176470588,8.133650519031143,3.564779934229079,0.024570317223641308,0.09438146129120856,0.055086924010925874,DMD/PCDH15,2
BP,GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,1/17,28/18805,0.03571428571428571,39.5063025210084,6.133481182865675,0.025023656201906386,0.09438146129120856,0.055086924010925874,DMD,1
BP,GO:0021544,subpallium development,1/17,28/18805,0.03571428571428571,39.5063025210084,6.133481182865675,0.025023656201906386,0.09438146129120856,0.055086924010925874,CNTNAP2,1
BP,GO:0021801,cerebral cortex radial glia-guided migration,1/17,28/18805,0.03571428571428571,39.5063025210084,6.133481182865675,0.025023656201906386,0.09438146129120856,0.055086924010925874,DAB1,1
BP,GO:0022030,telencephalon glial cell migration,1/17,28/18805,0.03571428571428571,39.5063025210084,6.133481182865675,0.025023656201906386,0.09438146129120856,0.055086924010925874,DAB1,1
BP,GO:1903599,positive regulation of autophagy of mitochondrion,1/17,28/18805,0.03571428571428571,39.5063025210084,6.133481182865675,0.025023656201906386,0.09438146129120856,0.055086924010925874,PRKN,1
BP,GO:0014046,dopamine secretion,1/17,29/18805,0.034482758620689655,38.14401622718053,6.021374336374508,0.025906363654884634,0.09468432026077304,0.05526369144824017,PRKN,1
BP,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,1/17,29/18805,0.034482758620689655,38.14401622718053,6.021374336374508,0.025906363654884634,0.09468432026077304,0.05526369144824017,ERBB4,1
BP,GO:0045686,negative regulation of glial cell differentiation,1/17,29/18805,0.034482758620689655,38.14401622718053,6.021374336374508,0.025906363654884634,0.09468432026077304,0.05526369144824017,DAB1,1
BP,GO:0070841,inclusion body assembly,1/17,29/18805,0.034482758620689655,38.14401622718053,6.021374336374508,0.025906363654884634,0.09468432026077304,0.05526369144824017,PRKN,1
BP,GO:0097107,postsynaptic density assembly,1/17,29/18805,0.034482758620689655,38.14401622718053,6.021374336374508,0.025906363654884634,0.09468432026077304,0.05526369144824017,PTPRD,1
BP,GO:1902914,regulation of protein polyubiquitination,1/17,29/18805,0.034482758620689655,38.14401622718053,6.021374336374508,0.025906363654884634,0.09468432026077304,0.05526369144824017,PRKN,1
BP,GO:1903421,regulation of synaptic vesicle recycling,1/17,29/18805,0.034482758620689655,38.14401622718053,6.021374336374508,0.025906363654884634,0.09468432026077304,0.05526369144824017,PRKN,1
BP,GO:0090140,regulation of mitochondrial fission,1/17,30/18805,0.03333333333333333,36.872549019607845,5.914829066932484,0.026788318907220554,0.09707368843263488,0.056658276159228735,PRKN,1
BP,GO:0051962,positive regulation of nervous system development,2/17,285/18805,0.007017543859649123,7.762641898864809,3.460410617857696,0.026795158550412534,0.09707368843263488,0.056658276159228735,PTPRD/LINGO2,2
BP,GO:0001963,"synaptic transmission, dopaminergic",1/17,31/18805,0.03225806451612903,35.68311195445921,5.813394616646947,0.02766952255987465,0.09936967667154983,0.057998358500789896,PRKN,1
BP,GO:0034315,regulation of Arp2/3 complex-mediated actin nucleation,1/17,31/18805,0.03225806451612903,35.68311195445921,5.813394616646947,0.02766952255987465,0.09936967667154983,0.057998358500789896,CTNNA2,1
BP,GO:0001736,establishment of planar polarity,1/17,32/18805,0.03125,34.568014705882355,5.716669857291346,0.028549975213357004,0.09992491324674951,0.05832242929401209,ERBB4,1
BP,GO:0007164,establishment of tissue polarity,1/17,32/18805,0.03125,34.568014705882355,5.716669857291346,0.028549975213357004,0.09992491324674951,0.05832242929401209,ERBB4,1
BP,GO:0010644,cell communication by electrical coupling,1/17,32/18805,0.03125,34.568014705882355,5.716669857291346,0.028549975213357004,0.09992491324674951,0.05832242929401209,PDE4D,1
BP,GO:0060045,positive regulation of cardiac muscle cell proliferation,1/17,32/18805,0.03125,34.568014705882355,5.716669857291346,0.028549975213357004,0.09992491324674951,0.05832242929401209,ERBB4,1
BP,GO:0060603,mammary gland duct morphogenesis,1/17,32/18805,0.03125,34.568014705882355,5.716669857291346,0.028549975213357004,0.09992491324674951,0.05832242929401209,CSMD1,1
BP,GO:2000649,regulation of sodium ion transmembrane transporter activity,1/17,32/18805,0.03125,34.568014705882355,5.716669857291346,0.028549975213357004,0.09992491324674951,0.05832242929401209,DMD,1
BP,GO:0010996,response to auditory stimulus,1/17,33/18805,0.030303030303030304,33.520499108734406,5.624296474743124,0.02942967746773195,0.10032235510487034,0.05855440122088775,CNTNAP2,1
BP,GO:0071875,adrenergic receptor signaling pathway,1/17,33/18805,0.030303030303030304,33.520499108734406,5.624296474743124,0.02942967746773195,0.10032235510487034,0.05855440122088775,PDE4D,1
BP,GO:0099560,synaptic membrane adhesion,1/17,33/18805,0.030303030303030304,33.520499108734406,5.624296474743124,0.02942967746773195,0.10032235510487034,0.05855440122088775,PTPRD,1
BP,GO:0007260,tyrosine phosphorylation of STAT protein,1/17,34/18805,0.029411764705882353,32.53460207612457,5.535953263838763,0.03030862992261396,0.10032235510487034,0.05855440122088775,ERBB4,1
BP,GO:0007628,adult walking behavior,1/17,34/18805,0.029411764705882353,32.53460207612457,5.535953263838763,0.03030862992261396,0.10032235510487034,0.05855440122088775,DAB1,1
BP,GO:0018198,peptidyl-cysteine modification,1/17,34/18805,0.029411764705882353,32.53460207612457,5.535953263838763,0.03030862992261396,0.10032235510487034,0.05855440122088775,DMD,1
BP,GO:0048710,regulation of astrocyte differentiation,1/17,34/18805,0.029411764705882353,32.53460207612457,5.535953263838763,0.03030862992261396,0.10032235510487034,0.05855440122088775,DAB1,1
BP,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/17,34/18805,0.029411764705882353,32.53460207612457,5.535953263838763,0.03030862992261396,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/17,34/18805,0.029411764705882353,32.53460207612457,5.535953263838763,0.03030862992261396,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0006874,intracellular calcium ion homeostasis,2/17,306/18805,0.006535947712418301,7.229911572472126,3.3050480328971146,0.030556531114615048,0.10032235510487034,0.05855440122088775,DMD/PDE4D,2
BP,GO:0008053,mitochondrial fusion,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0021772,olfactory bulb development,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,ERBB4,1
BP,GO:0046329,negative regulation of JNK cascade,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0050775,positive regulation of dendrite morphogenesis,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,PTPRD,1
BP,GO:0060544,regulation of necroptotic process,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0090075,relaxation of muscle,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,PDE4D,1
BP,GO:0098810,neurotransmitter reuptake,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0099633,protein localization to postsynaptic specialization membrane,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,ERBB4,1
BP,GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,ERBB4,1
BP,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,1/17,35/18805,0.02857142857142857,31.60504201680672,5.451351325954527,0.031186833177172524,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0010765,positive regulation of sodium ion transport,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,DMD,1
BP,GO:0032232,negative regulation of actin filament bundle assembly,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0032743,positive regulation of interleukin-2 production,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,PDE4D,1
BP,GO:0043388,positive regulation of DNA binding,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0086004,regulation of cardiac muscle cell contraction,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,PDE4D,1
BP,GO:0098698,postsynaptic specialization assembly,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,PTPRD,1
BP,GO:1901797,negative regulation of signal transduction by p53 class mediator,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:1902882,regulation of response to oxidative stress,1/17,36/18805,0.027777777777777776,30.727124183006534,5.370230005195559,0.032064287830128047,0.10032235510487034,0.05855440122088775,PRKN,1
BP,GO:0010770,positive regulation of cell morphogenesis,1/17,37/18805,0.02702702702702703,29.896661367249607,5.29235343257033,0.032940994479757624,0.10114967078170928,0.059037274395339435,PTPRD,1
BP,GO:0021799,cerebral cortex radially oriented cell migration,1/17,37/18805,0.02702702702702703,29.896661367249607,5.29235343257033,0.032940994479757624,0.10114967078170928,0.059037274395339435,DAB1,1
BP,GO:0021988,olfactory lobe development,1/17,37/18805,0.02702702702702703,29.896661367249607,5.29235343257033,0.032940994479757624,0.10114967078170928,0.059037274395339435,ERBB4,1
BP,GO:0045920,negative regulation of exocytosis,1/17,37/18805,0.02702702702702703,29.896661367249607,5.29235343257033,0.032940994479757624,0.10114967078170928,0.059037274395339435,PRKN,1
BP,GO:0097484,dendrite extension,1/17,37/18805,0.02702702702702703,29.896661367249607,5.29235343257033,0.032940994479757624,0.10114967078170928,0.059037274395339435,PRKN,1
BP,GO:0048854,brain morphogenesis,1/17,38/18805,0.02631578947368421,29.10990712074303,5.2175075734791445,0.03381695372388838,0.10307307666395497,0.06015989436993932,CTNNA2,1
BP,GO:0055023,positive regulation of cardiac muscle tissue growth,1/17,38/18805,0.02631578947368421,29.10990712074303,5.2175075734791445,0.03381695372388838,0.10307307666395497,0.06015989436993932,ERBB4,1
BP,GO:0048638,regulation of developmental growth,2/17,327/18805,0.0061162079510703364,6.765605324698687,3.163738731183622,0.03451763423006108,0.10412435612285671,0.06077348681568547,PRKN/ERBB4,2
BP,GO:0035633,maintenance of blood-brain barrier,1/17,39/18805,0.02564102564102564,28.363499245852186,5.145497694103963,0.034692166159903226,0.10412435612285671,0.06077348681568547,DMD,1
BP,GO:0045823,positive regulation of heart contraction,1/17,39/18805,0.02564102564102564,28.363499245852186,5.145497694103963,0.034692166159903226,0.10412435612285671,0.06077348681568547,PDE4D,1
BP,GO:0070979,protein K11-linked ubiquitination,1/17,39/18805,0.02564102564102564,28.363499245852186,5.145497694103963,0.034692166159903226,0.10412435612285671,0.06077348681568547,PRKN,1
BP,GO:0097193,intrinsic apoptotic signaling pathway,2/17,330/18805,0.006060606060606061,6.704099821746881,3.1445692964636063,0.03509934748857912,0.10412435612285671,0.06077348681568547,PRKN/WWOX,2
BP,GO:0055074,calcium ion homeostasis,2/17,331/18805,0.006042296072507553,6.683845743735561,3.1382325046441193,0.03529411788581929,0.10412435612285671,0.06077348681568547,DMD/PDE4D,2
BP,GO:0051125,regulation of actin nucleation,1/17,40/18805,0.025,27.654411764705884,5.076146178213074,0.035566632384740005,0.10412435612285671,0.06077348681568547,CTNNA2,1
BP,GO:0052652,cyclic purine nucleotide metabolic process,1/17,40/18805,0.025,27.654411764705884,5.076146178213074,0.035566632384740005,0.10412435612285671,0.06077348681568547,PDE4D,1
BP,GO:0060074,synapse maturation,1/17,40/18805,0.025,27.654411764705884,5.076146178213074,0.035566632384740005,0.10412435612285671,0.06077348681568547,DAB1,1
BP,GO:0090659,walking behavior,1/17,40/18805,0.025,27.654411764705884,5.076146178213074,0.035566632384740005,0.10412435612285671,0.06077348681568547,DAB1,1
BP,GO:1903524,positive regulation of blood circulation,1/17,40/18805,0.025,27.654411764705884,5.076146178213074,0.035566632384740005,0.10412435612285671,0.06077348681568547,PDE4D,1
BP,GO:0009187,cyclic nucleotide metabolic process,1/17,41/18805,0.024390243902439025,26.979913916786227,5.009290638498245,0.03644035299488946,0.10412435612285671,0.06077348681568547,PDE4D,1
BP,GO:0062098,regulation of programmed necrotic cell death,1/17,41/18805,0.024390243902439025,26.979913916786227,5.009290638498245,0.03644035299488946,0.10412435612285671,0.06077348681568547,PRKN,1
BP,GO:0090199,regulation of release of cytochrome c from mitochondria,1/17,41/18805,0.024390243902439025,26.979913916786227,5.009290638498245,0.03644035299488946,0.10412435612285671,0.06077348681568547,PRKN,1
BP,GO:1904861,excitatory synapse assembly,1/17,41/18805,0.024390243902439025,26.979913916786227,5.009290638498245,0.03644035299488946,0.10412435612285671,0.06077348681568547,PTPRD,1
BP,GO:0000266,mitochondrial fission,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,PRKN,1
BP,GO:0019933,cAMP-mediated signaling,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,PDE4D,1
BP,GO:0042417,dopamine metabolic process,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,PRKN,1
BP,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,ERBB4,1
BP,GO:0046676,negative regulation of insulin secretion,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,PRKN,1
BP,GO:0050433,regulation of catecholamine secretion,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,PRKN,1
BP,GO:0060421,positive regulation of heart growth,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,ERBB4,1
BP,GO:0060999,positive regulation of dendritic spine development,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,PTPRD,1
BP,GO:1903115,regulation of actin filament-based movement,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,PDE4D,1
BP,GO:2000008,regulation of protein localization to cell surface,1/17,42/18805,0.023809523809523808,26.337535014005603,4.94478227659984,0.03731332858639902,0.10412435612285671,0.06077348681568547,ERBB4,1
BP,GO:0007595,lactation,1/17,43/18805,0.023255813953488372,25.7250341997264,4.882484454017484,0.03818555975487059,0.10544460226585477,0.06154406504111316,ERBB4,1
BP,GO:0032956,regulation of actin cytoskeleton organization,2/17,348/18805,0.005747126436781609,6.357336037863421,3.034361087224612,0.038670567255569534,0.10544460226585477,0.06154406504111316,PRKN/CTNNA2,2
BP,GO:0015872,dopamine transport,1/17,44/18805,0.022727272727272728,25.140374331550802,4.822271442583469,0.039057047095461206,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0045494,photoreceptor cell maintenance,1/17,44/18805,0.022727272727272728,25.140374331550802,4.822271442583469,0.039057047095461206,0.10544460226585477,0.06154406504111316,PCDH15,1
BP,GO:0071364,cellular response to epidermal growth factor stimulus,1/17,44/18805,0.022727272727272728,25.140374331550802,4.822271442583469,0.039057047095461206,0.10544460226585477,0.06154406504111316,ERBB4,1
BP,GO:0030111,regulation of Wnt signaling pathway,2/17,350/18805,0.005714285714285714,6.321008403361344,3.0225970099784583,0.03907580719214771,0.10544460226585477,0.06154406504111316,PRKN/WWOX,2
BP,GO:0070588,calcium ion transmembrane transport,2/17,350/18805,0.005714285714285714,6.321008403361344,3.0225970099784583,0.03907580719214771,0.10544460226585477,0.06154406504111316,DMD/PDE4D,2
BP,GO:0021700,developmental maturation,2/17,352/18805,0.005681818181818182,6.285093582887701,3.010924245146985,0.03948271049436671,0.10544460226585477,0.06154406504111316,CNTNAP2/DAB1,2
BP,GO:0021517,ventral spinal cord development,1/17,45/18805,0.022222222222222223,24.58169934640523,4.764027328424962,0.03992779120288514,0.10544460226585477,0.06154406504111316,DAB1,1
BP,GO:0032092,positive regulation of protein binding,1/17,45/18805,0.022222222222222223,24.58169934640523,4.764027328424962,0.03992779120288514,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0043403,skeletal muscle tissue regeneration,1/17,45/18805,0.022222222222222223,24.58169934640523,4.764027328424962,0.03992779120288514,0.10544460226585477,0.06154406504111316,EYS,1
BP,GO:0061001,regulation of dendritic spine morphogenesis,1/17,45/18805,0.022222222222222223,24.58169934640523,4.764027328424962,0.03992779120288514,0.10544460226585477,0.06154406504111316,PTPRD,1
BP,GO:0001504,neurotransmitter uptake,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0014014,negative regulation of gliogenesis,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,DAB1,1
BP,GO:0021587,cerebellum morphogenesis,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,DAB1,1
BP,GO:0034314,Arp2/3 complex-mediated actin nucleation,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,CTNNA2,1
BP,GO:0060443,mammary gland morphogenesis,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,CSMD1,1
BP,GO:0097106,postsynaptic density organization,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,PTPRD,1
BP,GO:1901524,regulation of mitophagy,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:1903214,regulation of protein targeting to mitochondrion,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:1990000,amyloid fibril formation,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/17,46/18805,0.021739130434782608,24.047314578005114,4.707645047614861,0.04079779267141126,0.10544460226585477,0.06154406504111316,WWOX,1
BP,GO:0006936,muscle contraction,2/17,359/18805,0.005571030640668524,6.162543011633623,2.97077055911305,0.04091987666670968,0.10544460226585477,0.06154406504111316,DMD/PDE4D,2
BP,GO:0031346,positive regulation of cell projection organization,2/17,360/18805,0.005555555555555556,6.145424836601308,2.9651213047093425,0.0411268266424976,0.10544460226585477,0.06154406504111316,PTPRD/DMD,2
BP,GO:0010639,negative regulation of organelle organization,2/17,362/18805,0.0055248618784530384,6.11147221319467,2.9538865583984384,0.04154194887267251,0.10544460226585477,0.06154406504111316,PRKN/CTNNA2,2
BP,GO:1990778,protein localization to cell periphery,2/17,362/18805,0.0055248618784530384,6.11147221319467,2.9538865583984384,0.04154194887267251,0.10544460226585477,0.06154406504111316,KCNIP4/ERBB4,2
BP,GO:0003009,skeletal muscle contraction,1/17,47/18805,0.02127659574468085,23.53566958698373,4.653025535207808,0.04166705209486621,0.10544460226585477,0.06154406504111316,DMD,1
BP,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,1/17,47/18805,0.02127659574468085,23.53566958698373,4.653025535207808,0.04166705209486621,0.10544460226585477,0.06154406504111316,PTPRD,1
BP,GO:0090278,negative regulation of peptide hormone secretion,1/17,47/18805,0.02127659574468085,23.53566958698373,4.653025535207808,0.04166705209486621,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0002792,negative regulation of peptide secretion,1/17,48/18805,0.020833333333333332,23.0453431372549,4.600076972232294,0.042535570066632,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0008038,neuron recognition,1/17,48/18805,0.020833333333333332,23.0453431372549,4.600076972232294,0.042535570066632,0.10544460226585477,0.06154406504111316,CNTNAP2,1
BP,GO:0070266,necroptotic process,1/17,48/18805,0.020833333333333332,23.0453431372549,4.600076972232294,0.042535570066632,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0099054,presynapse assembly,1/17,48/18805,0.020833333333333332,23.0453431372549,4.600076972232294,0.042535570066632,0.10544460226585477,0.06154406504111316,PTPRD,1
BP,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,1/17,48/18805,0.020833333333333332,23.0453431372549,4.600076972232294,0.042535570066632,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0021575,hindbrain morphogenesis,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,DAB1,1
BP,GO:0021795,cerebral cortex cell migration,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,DAB1,1
BP,GO:0036323,vascular endothelial growth factor receptor-1 signaling pathway,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,ERBB4,1
BP,GO:0048489,synaptic vesicle transport,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0050432,catecholamine secretion,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0060043,regulation of cardiac muscle cell proliferation,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,ERBB4,1
BP,GO:0061028,establishment of endothelial barrier,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,PDE4D,1
BP,GO:0070849,response to epidermal growth factor,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,ERBB4,1
BP,GO:1904894,positive regulation of receptor signaling pathway via STAT,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,ERBB4,1
BP,GO:2000378,negative regulation of reactive oxygen species metabolic process,1/17,49/18805,0.02040816326530612,22.575030012004802,4.548714117582911,0.043403347179649665,0.10544460226585477,0.06154406504111316,PRKN,1
BP,GO:0050767,regulation of neurogenesis,2/17,372/18805,0.005376344086021506,5.947185325743201,2.8989514646757186,0.04364179591823404,0.10571297193097161,0.06170070236317701,PTPRD/DAB1,2
BP,GO:0042551,neuron maturation,1/17,50/18805,0.02,22.123529411764707,4.498857713724669,0.04427038402641592,0.1063003988541266,0.062043561456849736,CNTNAP2,1
BP,GO:0044788,modulation by host of viral process,1/17,50/18805,0.02,22.123529411764707,4.498857713724669,0.04427038402641592,0.1063003988541266,0.062043561456849736,PRKN,1
BP,GO:1903573,negative regulation of response to endoplasmic reticulum stress,1/17,50/18805,0.02,22.123529411764707,4.498857713724669,0.04427038402641592,0.1063003988541266,0.062043561456849736,PRKN,1
BP,GO:0006513,protein monoubiquitination,1/17,51/18805,0.0196078431372549,21.68973471741638,4.450433956759487,0.04513668119898595,0.10744351201833544,0.06271075379686203,PRKN,1
BP,GO:1902305,regulation of sodium ion transmembrane transport,1/17,51/18805,0.0196078431372549,21.68973471741638,4.450433956759487,0.04513668119898595,0.10744351201833544,0.06271075379686203,DMD,1
BP,GO:1903146,regulation of autophagy of mitochondrion,1/17,51/18805,0.0196078431372549,21.68973471741638,4.450433956759487,0.04513668119898595,0.10744351201833544,0.06271075379686203,PRKN,1
BP,GO:0036215,response to stem cell factor,1/17,52/18805,0.019230769230769232,21.272624434389144,4.403374022774203,0.04600223928897296,0.10825598191650046,0.06318496204633263,ERBB4,1
BP,GO:0036216,cellular response to stem cell factor stimulus,1/17,52/18805,0.019230769230769232,21.272624434389144,4.403374022774203,0.04600223928897296,0.10825598191650046,0.06318496204633263,ERBB4,1
BP,GO:0038109,Kit signaling pathway,1/17,52/18805,0.019230769230769232,21.272624434389144,4.403374022774203,0.04600223928897296,0.10825598191650046,0.06318496204633263,ERBB4,1
BP,GO:1903747,regulation of establishment of protein localization to mitochondrion,1/17,52/18805,0.019230769230769232,21.272624434389144,4.403374022774203,0.04600223928897296,0.10825598191650046,0.06318496204633263,PRKN,1
BP,GO:0031648,protein destabilization,1/17,53/18805,0.018867924528301886,20.871254162042174,4.357613643538009,0.046867058887548385,0.10966626243941915,0.064008089967189985,PRKN,1
BP,GO:1903539,protein localization to postsynaptic membrane,1/17,53/18805,0.018867924528301886,20.871254162042174,4.357613643538009,0.046867058887548385,0.10966626243941915,0.064008089967189985,ERBB4,1
BP,GO:0001836,release of cytochrome c from mitochondria,1/17,54/18805,0.018518518518518517,20.48474945533769,4.313092725584249,0.04773114058544248,0.10982151009352503,0.06409870220827639,PRKN,1
BP,GO:0038145,macrophage colony-stimulating factor signaling pathway,1/17,54/18805,0.018518518518518517,20.48474945533769,4.313092725584249,0.04773114058544248,0.10982151009352503,0.06409870220827639,ERBB4,1
BP,GO:0046622,positive regulation of organ growth,1/17,54/18805,0.018518518518518517,20.48474945533769,4.313092725584249,0.04773114058544248,0.10982151009352503,0.06409870220827639,ERBB4,1
BP,GO:0050771,negative regulation of axonogenesis,1/17,54/18805,0.018518518518518517,20.48474945533769,4.313092725584249,0.04773114058544248,0.10982151009352503,0.06409870220827639,DAB1,1
BP,GO:0062237,protein localization to postsynapse,1/17,54/18805,0.018518518518518517,20.48474945533769,4.313092725584249,0.04773114058544248,0.10982151009352503,0.06409870220827639,ERBB4,1
BP,GO:0071320,cellular response to cAMP,1/17,54/18805,0.018518518518518517,20.48474945533769,4.313092725584249,0.04773114058544248,0.10982151009352503,0.06409870220827639,PDE4D,1
BP,GO:0031547,brain-derived neurotrophic factor receptor signaling pathway,1/17,55/18805,0.01818181818181818,20.11229946524064,4.2697550075284,0.04859448497294416,0.11027210051552713,0.06436169496127365,ERBB4,1
BP,GO:0035790,platelet-derived growth factor receptor-alpha signaling pathway,1/17,55/18805,0.01818181818181818,20.11229946524064,4.2697550075284,0.04859448497294416,0.11027210051552713,0.06436169496127365,ERBB4,1
BP,GO:0050885,neuromuscular process controlling balance,1/17,55/18805,0.01818181818181818,20.11229946524064,4.2697550075284,0.04859448497294416,0.11027210051552713,0.06436169496127365,PCDH15,1
BP,GO:0099084,postsynaptic specialization organization,1/17,55/18805,0.01818181818181818,20.11229946524064,4.2697550075284,0.04859448497294416,0.11027210051552713,0.06436169496127365,PTPRD,1
BP,GO:1903351,cellular response to dopamine,1/17,55/18805,0.01818181818181818,20.11229946524064,4.2697550075284,0.04859448497294416,0.11027210051552713,0.06436169496127365,PRKN,1
BP,GO:1902903,regulation of supramolecular fiber organization,2/17,396/18805,0.005050505050505051,5.5867498514557346,2.774896926269286,0.04884232838616994,0.11053085821089416,0.06451272213659939,PRKN/CTNNA2,2
BP,GO:0001738,morphogenesis of a polarized epithelium,1/17,56/18805,0.017857142857142856,19.7531512605042,4.227547751166383,0.0494570926399025,0.11112387400974823,0.064858843247693,ERBB4,1
BP,GO:0086065,cell communication involved in cardiac conduction,1/17,56/18805,0.017857142857142856,19.7531512605042,4.227547751166383,0.0494570926399025,0.11112387400974823,0.064858843247693,PDE4D,1
BP,GO:2001233,regulation of apoptotic signaling pathway,2/17,399/18805,0.005012531328320802,5.544744213474864,2.760104280084292,0.04950797292443989,0.11112387400974823,0.064858843247693,PRKN/WWOX,2
CC,GO:0097060,synaptic membrane,6/18,452/19880,0.01327433628318584,14.660766961651916,8.844072282944957,1.967185762394974e-6,1.51473303704413e-4,9.318248348186719e-5,PTPRD/CNTNAP2/DMD/LINGO2/NRXN3/ERBB4,6
CC,GO:0042734,presynaptic membrane,4/18,181/19880,0.022099447513812154,24.407612031921424,9.523494572428692,1.84083026270704e-5,7.087196511422104e-4,4.3598611485166737e-4,PTPRD/CNTNAP2/NRXN3/ERBB4,4
CC,GO:0034703,cation channel complex,3/18,223/19880,0.013452914798206279,14.857997010463379,6.264931208582495,0.0010033536454771609,0.022465850428176087,0.01382041379723751,CNTNAP2/KCNIP4/PDE4D,3
CC,GO:0098858,actin-based cell projection,3/18,235/19880,0.01276595744680851,14.099290780141843,6.081038149532153,0.0011670571651000564,0.022465850428176087,0.01382041379723751,DMD/PCDH15/WWOX,3
CC,GO:0008076,voltage-gated potassium channel complex,2/18,89/19880,0.02247191011235955,24.81897627965044,6.779634116398857,0.0028940021808413286,0.036163104542816724,0.02224661250070748,CNTNAP2/KCNIP4,2
CC,GO:0001750,photoreceptor outer segment,2/18,94/19880,0.02127659574468085,23.498817966903076,6.582133053065492,0.003221621852928166,0.036163104542816724,0.02224661250070748,EYS/PCDH15,2
CC,GO:0034705,potassium channel complex,2/18,100/19880,0.02,22.08888888888889,6.364475011116787,0.0036366733564781716,0.036163104542816724,0.02224661250070748,CNTNAP2/KCNIP4,2
CC,GO:0034702,monoatomic ion channel complex,3/18,361/19880,0.008310249307479225,9.178208679593721,4.720685169941037,0.003957005451025231,0.036163104542816724,0.02224661250070748,CNTNAP2/KCNIP4/PDE4D,3
CC,GO:0098982,GABA-ergic synapse,2/18,108/19880,0.018518518518518517,20.45267489711934,6.102221056829166,0.004226856375134422,0.036163104542816724,0.02224661250070748,CNTNAP2/ERBB4,2
CC,GO:0097733,photoreceptor cell cilium,2/18,120/19880,0.016666666666666666,18.407407407407405,5.757756274969679,0.005189796434383342,0.039961432544751735,0.024583246268131617,EYS/PCDH15,2
CC,GO:0098984,neuron to neuron synapse,3/18,414/19880,0.007246376811594203,8.003220611916264,4.3349256104550635,0.0057979623878641395,0.040067295704678124,0.024648370563370003,PTPRD/PRKN/ERBB4,3
CC,GO:0097731,9+0 non-motile cilium,2/18,132/19880,0.015151515151515152,16.734006734006737,5.459926151424551,0.006244253876053734,0.040067295704678124,0.024648370563370003,EYS/PCDH15,2
CC,GO:1902495,transmembrane transporter complex,3/18,498/19880,0.006024096385542169,6.653279785809906,3.8462533454534804,0.009634708226041361,0.05204345338704203,0.03201579497494041,CNTNAP2/KCNIP4/PDE4D,3
CC,GO:0097730,non-motile cilium,2/18,169/19880,0.011834319526627219,13.07034845496384,4.743849055376951,0.010051836068146594,0.05204345338704203,0.03201579497494041,EYS/PCDH15,2
CC,GO:0033270,paranode region of axon,1/18,12/19880,0.08333333333333333,92.03703703703702,9.496283957230334,0.010814224080424317,0.05204345338704203,0.03201579497494041,CNTNAP2,1
CC,GO:0044224,juxtaparanode region of axon,1/18,12/19880,0.08333333333333333,92.03703703703702,9.496283957230334,0.010814224080424317,0.05204345338704203,0.03201579497494041,CNTNAP2,1
CC,GO:0030673,axolemma,1/18,15/19880,0.06666666666666667,73.62962962962962,8.471049216255256,0.013500470133777753,0.05775201112782705,0.035527552983625664,CNTNAP2,1
CC,GO:0098691,dopaminergic synapse,1/18,15/19880,0.06666666666666667,73.62962962962962,8.471049216255256,0.013500470133777753,0.05775201112782705,0.035527552983625664,PRKN,1
CC,GO:0016010,dystrophin-associated glycoprotein complex,1/18,18/19880,0.05555555555555555,61.35802469135802,7.71226267209365,0.016179825608799048,0.05932602723226317,0.03649584723789259,DMD,1
CC,GO:0031527,filopodium membrane,1/18,18/19880,0.05555555555555555,61.35802469135802,7.71226267209365,0.016179825608799048,0.05932602723226317,0.03649584723789259,DMD,1
CC,GO:0043034,costamere,1/18,18/19880,0.05555555555555555,61.35802469135802,7.71226267209365,0.016179825608799048,0.05932602723226317,0.03649584723789259,DMD,1
CC,GO:0140047,specialized extracellular matrix,1/18,22/19880,0.045454545454545456,50.2020202020202,6.951020235917472,0.019741609649768677,0.06906615717191794,0.04248772484943687,EYS,1
CC,GO:0090665,glycoprotein complex,1/18,23/19880,0.043478260869565216,48.01932367149758,6.792122477890664,0.020630150843559902,0.06906615717191794,0.04248772484943687,DMD,1
CC,GO:0016342,catenin complex,1/18,31/19880,0.03225806451612903,35.62724014336917,5.80833210915543,0.027711146660824637,0.08890659553681238,0.054693052620048636,CTNNA2,1
CC,GO:0016235,aggresome,1/18,35/19880,0.02857142857142857,31.555555555555557,5.446539850605735,0.03123348562554562,0.09619913572668051,0.05917923592208643,PRKN,1
CC,GO:0045211,postsynaptic membrane,2/18,321/19880,0.006230529595015576,6.881273797161647,3.1979570120939953,0.03353839785688957,0.09932525519155758,0.06110234427368545,DMD/ERBB4,2
CC,GO:0005891,voltage-gated calcium channel complex,1/18,45/19880,0.022222222222222223,24.54320987654321,4.759681137705839,0.03998668174159137,0.10974498639346646,0.06751229511559795,PDE4D,1
CC,GO:0031253,cell projection membrane,2/18,359/19880,0.005571030640668524,6.152893840916125,2.965988204095818,0.04112471521689688,0.10974498639346646,0.06751229511559795,CNTNAP2/DMD,2
CC,GO:0014069,postsynaptic density,2/18,360/19880,0.005555555555555556,6.135802469135802,2.960340632061317,0.041332527342993856,0.10974498639346646,0.06751229511559795,PRKN/ERBB4,2
CC,GO:0098686,hippocampal mossy fiber to CA3 synapse,1/18,49/19880,0.02040816326530612,22.539682539682538,4.544509980926972,0.04346700137270221,0.11105998865437111,0.06832125071013943,PTPRD,1
CC,GO:0032279,asymmetric synapse,2/18,376/19880,0.005319148936170213,5.874704491725769,2.872780224342018,0.04471246296474681,0.11105998865437111,0.06832125071013943,PRKN/ERBB4,2
CC,GO:0099572,postsynaptic specialization,2/18,396/19880,0.005050505050505051,5.578002244668912,2.7701709103811614,0.04907924117113258,0.11809692406803778,0.0726501925230581,PRKN/ERBB4,2
MF,GO:0008013,beta-catenin binding,2/17,106/18639,0.018867924528301886,20.687014428412876,6.14144946466081,0.004121022637833878,0.09032938228478822,0.04532020163821151,PRKN/CTNNA2,2
MF,GO:0005200,structural constituent of cytoskeleton,2/17,112/18639,0.017857142857142856,19.578781512605044,5.958468410761811,0.004588348844900613,0.09032938228478822,0.04532020163821151,DMD/CTNNA2,2
MF,GO:0002020,protease binding,2/17,136/18639,0.014705882352941176,16.12370242214533,5.348320892458358,0.006689796244083886,0.09032938228478822,0.04532020163821151,CNTNAP2/PRKN,2
MF,GO:0044325,transmembrane transporter binding,2/17,136/18639,0.014705882352941176,16.12370242214533,5.348320892458358,0.006689796244083886,0.09032938228478822,0.04532020163821151,CNTNAP2/PDE4D,2
MF,GO:0003779,actin binding,3/17,443/18639,0.006772009029345372,7.424910370468729,4.135156263531669,0.007075973605270264,0.09032938228478822,0.04532020163821151,PRKN/DMD/CTNNA2,3
MF,GO:0099106,ion channel regulator activity,2/17,160/18639,0.0125,13.70514705882353,4.876535701757495,0.009151367932560557,0.09032938228478822,0.04532020163821151,KCNIP4/PDE4D,2
MF,GO:0002162,dystroglycan binding,1/17,11/18639,0.09090909090909091,99.67379679144385,9.890677028418027,0.009989767365644275,0.09032938228478822,0.04532020163821151,DMD,1
MF,GO:0050998,nitric-oxide synthase binding,1/17,11/18639,0.09090909090909091,99.67379679144385,9.890677028418027,0.009989767365644275,0.09032938228478822,0.04532020163821151,DMD,1
MF,GO:0016247,channel regulator activity,2/17,168/18639,0.011904761904761904,13.05252100840336,4.741309295572267,0.010049360818512933,0.09032938228478822,0.04532020163821151,KCNIP4/PDE4D,2
MF,GO:0141108,transporter regulator activity,2/17,170/18639,0.011764705882352941,12.898961937716264,4.708936115739098,0.010279791973833536,0.09032938228478822,0.04532020163821151,KCNIP4/PDE4D,2
MF,GO:0017166,vinculin binding,1/17,12/18639,0.08333333333333333,91.36764705882354,9.461131820614009,0.010893255338308316,0.09032938228478822,0.04532020163821151,DMD,1
MF,GO:0005041,low-density lipoprotein particle receptor activity,1/17,15/18639,0.06666666666666667,73.09411764705882,8.439562469793854,0.013599065351345696,0.09032938228478822,0.04532020163821151,LRP1B,1
MF,GO:0005001,transmembrane receptor protein tyrosine phosphatase activity,1/17,17/18639,0.058823529411764705,64.49480968858131,7.913351895165834,0.015399066683243756,0.09032938228478822,0.04532020163821151,PTPRD,1
MF,GO:0019198,transmembrane receptor protein phosphatase activity,1/17,17/18639,0.058823529411764705,64.49480968858131,7.913351895165834,0.015399066683243756,0.09032938228478822,0.04532020163821151,PTPRD,1
MF,GO:0030228,lipoprotein particle receptor activity,1/17,18/18639,0.05555555555555555,60.911764705882355,7.683477391190574,0.016297907616891094,0.09032938228478822,0.04532020163821151,LRP1B,1
MF,GO:0031690,adrenergic receptor binding,1/17,18/18639,0.05555555555555555,60.911764705882355,7.683477391190574,0.016297907616891094,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0050811,GABA receptor binding,1/17,18/18639,0.05555555555555555,60.911764705882355,7.683477391190574,0.016297907616891094,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:1990381,ubiquitin-specific protease binding,1/17,18/18639,0.05555555555555555,60.911764705882355,7.683477391190574,0.016297907616891094,0.09032938228478822,0.04532020163821151,PRKN,1
MF,GO:0043274,phospholipase binding,1/17,23/18639,0.043478260869565216,47.67007672634271,6.766595272277635,0.020780539853739177,0.09032938228478822,0.04532020163821151,PRKN,1
MF,GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activity",1/17,23/18639,0.043478260869565216,47.67007672634271,6.766595272277635,0.020780539853739177,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0004114,"3',5'-cyclic-nucleotide phosphodiesterase activity",1/17,24/18639,0.041666666666666664,45.68382352941177,6.6181313414504155,0.02167475616349912,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0004115,"3',5'-cyclic-AMP phosphodiesterase activity",1/17,24/18639,0.041666666666666664,45.68382352941177,6.6181313414504155,0.02167475616349912,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0030552,cAMP binding,1/17,24/18639,0.041666666666666664,45.68382352941177,6.6181313414504155,0.02167475616349912,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0004112,cyclic-nucleotide phosphodiesterase activity,1/17,26/18639,0.038461538461538464,42.16968325791856,6.346977580845397,0.023460883606909344,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0097602,cullin family protein binding,1/17,26/18639,0.038461538461538464,42.16968325791856,6.346977580845397,0.023460883606909344,0.09032938228478822,0.04532020163821151,PRKN,1
MF,GO:0031624,ubiquitin conjugating enzyme binding,1/17,30/18639,0.03333333333333333,36.54705882352941,5.887267041861832,0.02702393511539114,0.09032938228478822,0.04532020163821151,PRKN,1
MF,GO:0001664,G protein-coupled receptor binding,2/17,297/18639,0.006734006734006734,7.383244206773618,3.3504820308584176,0.029396240887183043,0.09032938228478822,0.04532020163821151,PRKN/PDE4D,2
MF,GO:0005154,epidermal growth factor receptor binding,1/17,35/18639,0.02857142857142857,31.326050420168063,5.425723559370507,0.03146054410162524,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0044390,ubiquitin-like protein conjugating enzyme binding,1/17,36/18639,0.027777777777777776,30.455882352941178,5.344938926820506,0.03234557800563875,0.09032938228478822,0.04532020163821151,PRKN,1
MF,GO:0019213,deacetylase activity,1/17,37/18639,0.02702702702702703,29.63275039745628,5.267384999462,0.033229850712938935,0.09032938228478822,0.04532020163821151,MACROD2,1
MF,GO:0030551,cyclic nucleotide binding,1/17,37/18639,0.02702702702702703,29.63275039745628,5.267384999462,0.033229850712938935,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",1/17,39/18639,0.02564102564102564,28.1131221719457,5.1211360738946725,0.03499611499214572,0.09032938228478822,0.04532020163821151,MACROD2,1
MF,GO:0008307,structural constituent of muscle,1/17,42/18639,0.023809523809523808,26.10504201680672,4.921246347379562,0.03763981776565328,0.09032938228478822,0.04532020163821151,DMD,1
MF,GO:0042578,phosphoric ester hydrolase activity,2/17,363/18639,0.005509641873278237,6.040836169178415,2.9303957368289573,0.04242523862211735,0.09032938228478822,0.04532020163821151,PTPRD/PDE4D,2
MF,GO:0005004,GPI-linked ephrin receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005008,hepatocyte growth factor receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005009,insulin receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005011,macrophage colony-stimulating factor receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005018,platelet-derived growth factor alpha-receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005020,stem cell factor receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0008288,boss receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0036332,placental growth factor receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0038062,protein tyrosine kinase collagen receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0060175,brain-derived neurotrophic factor receptor activity,1/17,49/18639,0.02040816326530612,22.375750300120046,4.526793316326711,0.043781972819125325,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005006,epidermal growth factor receptor activity,1/17,50/18639,0.02,21.92823529411765,4.477138722975757,0.044656405657321874,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005007,fibroblast growth factor receptor activity,1/17,50/18639,0.02,21.92823529411765,4.477138722975757,0.044656405657321874,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005017,platelet-derived growth factor receptor activity,1/17,50/18639,0.02,21.92823529411765,4.477138722975757,0.044656405657321874,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005019,platelet-derived growth factor beta-receptor activity,1/17,50/18639,0.02,21.92823529411765,4.477138722975757,0.044656405657321874,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005010,insulin-like growth factor receptor activity,1/17,51/18639,0.0196078431372549,21.49826989619377,4.428910626208926,0.045530085850114754,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005021,vascular endothelial growth factor receptor activity,1/17,51/18639,0.0196078431372549,21.49826989619377,4.428910626208926,0.045530085850114754,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005030,neurotrophin receptor activity,1/17,51/18639,0.0196078431372549,21.49826989619377,4.428910626208926,0.045530085850114754,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0030544,Hsp70 protein binding,1/17,51/18639,0.0196078431372549,21.49826989619377,4.428910626208926,0.045530085850114754,0.09032938228478822,0.04532020163821151,PRKN,1
MF,GO:0005003,ephrin receptor activity,1/17,53/18639,0.018867924528301886,20.687014428412876,4.3364643579316215,0.04727519072848729,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005005,transmembrane-ephrin receptor activity,1/17,53/18639,0.018867924528301886,20.687014428412876,4.3364643579316215,0.04727519072848729,0.09032938228478822,0.04532020163821151,ERBB4,1
MF,GO:0005246,calcium channel regulator activity,1/17,53/18639,0.018867924528301886,20.687014428412876,4.3364643579316215,0.04727519072848729,0.09032938228478822,0.04532020163821151,PDE4D,1
MF,GO:0038064,collagen receptor activity,1/17,53/18639,0.018867924528301886,20.687014428412876,4.3364643579316215,0.04727519072848729,0.09032938228478822,0.04532020163821151,ERBB4,1
